Chemotherapy Plus EGFR-TKI as First-Line Treatment Provides Better Survival for Advanced EGFR-Positive Lung Adenocarcinoma Patients: Updated Data and Exploratory In Vitro Study.
Yuqing LouJianlin XuYanwei ZhangJun LuTianqing ChuXueyan ZhangHuimin WangHua ZhongWei ZhangBao-Hui HanPublished in: Targeted oncology (2020)
NCT02148380.